Christine Brezden-Masley, MD PhD FRCPC

Christine Brezden-Masley, MD PhD FRCPC is a senior practicing Medical Oncologist and the Medical Director of the Cancer Program at Sinai Health System in Toronto, Canada. She is also the Director of the Marvelle Koffler Breast Centre at Sinai Health and holds the Marvelle Koffler Chair in Breast Research. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is a Full Professor at the Temerty Faculty of Medicine, University of Toronto and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is the Past-President of the Canadian Cardio-Oncology Network (2017-2022). She also serves on the International Cardio-Oncology Society (ICOS) annual summit steering committees. She co-chairs the Junior Mentoring Program JuMP that fosters mentorship/sponsorship of junior medical oncology faculty across Canada and serves on the executive of WinC (Women in Cancer/All in Cancer). She is an advocate for patients and serves as a board member of ReThink Breast Cancer and MyGutFeeling and also serves on the scientific committee for the Colorectal Cancer Resource & Action Network.
Financial relationships
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:AstellasTopic:Clinical trial and Advisory BoardDate added:02/24/2025Date updated:02/24/2025Relationship end date:08/01/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Astra ZenecaTopic:Clinical trial; Research grant; Advisory Board; Speaker feesDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2028
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:BMSTopic:Research; Speaker fees; Advisory boardDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2028
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:BeigeneTopic:Advisory boardDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/23/2026
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Daiichi-SankyoTopic:Advisory board; Speaker fees; Clinical trialDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:KnightTopic:Advisory board; Speaker feesDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Gilead SciencesTopic:Clinical trial, Speaker fees, Advisory boardDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Eli LillyTopic:Advisory board, Speaker fees, Research GrantDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:MerckTopic:Advisory board, Clinical trial, Speaker feesDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:NovartisTopic:Clinical trial, Research Grant, Speaker feesDate added:02/24/2025Date updated:02/24/2025Relationship end date:02/28/2027
Pages
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward